Browse

ANTIBIOTIC PROPHYLAXIS FOR REVISION, CLEAN HEAD AND NECK SURGERY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Clinical Trials in H&N Surgery

Yotam Shkedy, MD, Sagit Stern, MD, Yuval Nachalon, MD, Dana Levy, RN, Inga Mansharov, RN, Ella Rifen, MD, Thomas Shpitzer, MD

Rabin Medical Center

SUBMENTAL LIPOSUCTION FOR THE MANAGEMENT OF LYMPHEDEMA FOLLOWING HEAD AND NECK CANCER TREATMENT: A RANDOMIZED CONTROLLED TRIAL.

Clinical Trials in H&N Surgery

Uthman Alamoudi, MD, Benjamin Taylor, MD, Matthew Rigby, MD, MPH, FRCSC, Robert Hart, MD, FRCSC, Jonathan Trites, MD, FRCSC, S. Mark Taylor, MD, FRCSC

Dalhousie University

ANTI-OX-40 (MEDI6469) PRIOR TO DEFINITIVE SURGICAL RESECTION IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA

Immunobiology / Immunotherapy of H&N Cancer

R. Bryan Bell, MD, DDS, FACS¹, Rom S Leidner, MD¹, Zipei Feng, MD, PhD², Rebekka Duhen, PhD¹, Yoshi Koguchi, PhD¹, Carlo Bifulco, MD¹, Bernard A Fox, PhD¹, Brendan Curti, MD¹, Andrew D Weinberg, PhD¹

¹Earle A. Chiles Research Institute at Providence Cancer Center, ²Oregon Health & Science University

THE ROLE OF TLR3 SIGNALING IN CHEMORESISTANCE OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

Immunobiology / Immunotherapy of H&N Cancer

Hui-Ching Chuang, MD, PhD

Kaoshiung Chang Gung Memorial Hospital

LOSS OF PROTECTIVE CD169 MACROPHAGES IN LYMPH NODES WITH METASTATIC SQUAMOUS CELL CARCINOMA WITH PRESERVATION IN ADJACENT NEGATIVE DRAINING LYMPH NODES

Immunobiology / Immunotherapy of H&N Cancer

Michael C Topf, MD, Christopher M Shumrick, BS, Madalina Tuluc, MD, David M Cognetti, MD, Joseph M Curry, MD, Adam Luginbuhl, MD

Thomas Jefferson University Hospital

CETUXIMAB AND CISPLATIN EFFECTS ON OROSPHERE FORMATION AND GENE EXPRESSION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) CELLS: THE POTENTIAL FOR A PROGNOSTIC BIOMARKER

Immunobiology / Immunotherapy of H&N Cancer

Valeda Yong, BA¹, Lechuang Chen, MD, PhD², Ashlee Jeter, BS², Chad Zender, MD, FACS³, Ge Jin, PhD², Aaron Weinberg, DMD, PhD²

¹Case Western Reserve University School of Medicine, ²Case Western Reserve School of Dental Medicine - Biological Sciences, ³University Hospitals Cleveland Medical Center - ENT Institute

LONG-TERM OUTCOMES OF PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Non Melanoma Skin Cancers

1, Gary Clayman, MD², Jack Lee, PhD¹, Adel El-Naggar, MD¹, Victor Prieto, MD¹, Bonnie Glisson, MD¹, Dianna Roberts, PhD¹, Michael Migden, MD¹, Jeffrey Myers, MD, PhD¹, Randal Weber, MD¹, Neil D Gross, MD¹

¹The University Of Texas MD Anderson Cancer Center, ²Clayman Thyroid Cancer Center

PREDICTORS OF RECURRENCE AND METASTASIS IN ACINIC CELL CARCINOMA OF THE PAROTID GLAND

Non Melanoma Skin Cancers

S. Ahmed Ali, MD, Kevin J Kovatch, MD, Andrew J Rosko, Andrew C Birkeland, MD, Kelly M Malloy, MD, Carol R Bradford, MD, Mark E Prince, MD, Jonathan B McHugh, MD, Matthew E Spector, MD

University of Michigan Health System

PROGNOSTIC FACTORS OF CUTANEOUS SQUAMOUS CELL CARCINOMA IN THE HEAD & NECK AND THE ROLE OF SENTINEL LYMPH NODE BIOPSY: A SYSTEMATIC REVIEW OF THE LITERATURE

Non Melanoma Skin Cancers

Joshua Lubov, Michael Hier, MD, Manish Khanna, MD, Khalil Sultanem, MD, Alex Mlynarek, MD

McGill University

COMPARISON OF THE CLINICOPATHOLOGIC FEATURES OF ONCOCYTIC VARIANT PAPILLARY THYROID CARCINOMA WITH CLASSICAL AND FOLLICULAR SUBTYPES

Endocrine Surgery

Carol Li, MD, Paul H McClelland, BA, Andrew Tassler, MD, William I Kuhel, MD, Theresa Scognamiglio, MD, David I Kutler, MD

New York Presbyterian - Weill Cornell Medical College